Absci

3.06
Open
3.02
Market Cap
468.25M+
High
3.29
Low
2.96
Close
3.06
Volume
4.68M+
P/E Ratio
-3.26
Div/Yield
0.00%

About Absci

Absci Corporation 是一家藥物和靶標發現公司,使用集成的藥物創建平台為美國的合作夥伴提供生物候選藥物和生產細胞系。其集成的藥物創造平台通過將藥物發現和細胞系開發過程統一為一個過程來實現生物製劑的創造。 Absci Corporation 成立於 2011 年,總部位於華盛頓州溫哥華市。

如何購買 Absci (ABSI)

登入
1分鐘開戶

1分鐘開戶

僅需1分鐘即可完成帳戶申請和驗證。整個過程完全自助,支援 RockFlow App 和網頁端操作。

充值資金

充值資金

帳戶驗證完成後,您可以使用首選的支付方式向帳戶充值。

購買 ABSI

購買 ABSI

透過 RockFlow App 或網頁端搜尋 ABSI,輸入您想要投資的金額,然後點擊確認即可完成交易。

logo

Social

Download

google playapp store

© Rockalpha Limited. All Rights Reserved.

Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.